SPRC Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio0.08
EPS (TTM)$98.070.0% YoY
Profit margin0.0%HEALTHCARE
Market cap$4.3MMicro cap
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 1.09
- P/S (TTM)
- 5.04
- EV/EBITDA
- 1.21
Profitability & growth
- ROE (TTM)
- -178.4%
- Operating margin
- -849.0%
- Revenue growth YoY
- -34.5%
- Dividend yield
- —
- Beta
- 2.43
Last earnings
Apr 24, 2025 · Estimate $0.00 · Reported $-6.20
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Scisparc Ltd
Company profileSciSparc Ltd., a specialized clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. The company is headquartered in Tel Aviv, Israel.
Classification
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- TOWER A, TEL AVIV-YAFO, ISRAEL
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$4.3M
Shares outstanding$573240
52W high$80.10
52W low$2.98
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent